9 results
dm2 management inhibitors insulin medications aace agonists antidiabetic based calculation carbratio control decisionaid dpp4 estimation g glp1 glycemic icr isf
AACE/ACE 2018 Glycemic Control Algorithm #AACE #2018 #Glycemic #Diabetes #DM2 #Control #Medication #Algorithm #Endocrinology #PrimaryCare #Management
Control Algorithm ... #AACE #2018 # ... Glycemic #Diabetes ... #DM2 #Control # ... #Endocrinology
Profiles of Antidiabetic Medications - AACE 2018 #Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
Medications - AACE 2018 ... DecisionAid #Orals #DM2 ... #Diabetes #Endocrinology ... #Pharmacology #
Sulfonylureas - Pharmacology Summary Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
Sulfonylureas - Pharmacology ... pancreatic beta cells ... Sulfonylureas #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
Estimating the Total Daily Dose (TDD) of Insulin: Weight-Based Dosing TDD in units of insulin = N
: Weight-Based Dosing ... #TDD #Insulin #dosing ... Weight #Based #pharmacology ... #endocrinology ... #diabetes #DM2
SGLT2 Inhibitors SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
being approved in 2013 ... These work by inhibiting ... SGLT2 #Inhibitors #Pharmacology ... #Medications #DM2 ... #Diabetes #Endocrinology
GLP-1 Agonists Adlyxin (Lixisenatide) Daily Bydureon (Exenatide ER) Weekly Ozempic (Semaglutide) Weekly Trulicity (Dulaglutide) Weekly Victoza (Liraglutide) Daily
to treat Type 2 Diabetes ... They work primarily ... GLP1 #Agonists #Pharmacology ... #Dosing #Diabetes ... #DM2 #Endocrinology
DPP4 Inhibitors - Normal and Renal Dosing Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... DPP4 inhibitors work ... #Pharmacology # ... Management #Diabetes ... #DM2 #Endocrinology
Insulin Calculations for Type 1 Diabetes Insulin-to-Carb Ratio (ICR) 500/TDD = #g of carbs covered by
Calculations for Type 1 Diabetes ... calculations used in dosing ... The ICR tells us ... #DM1 #Pharmacology ... #Endocrinology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist Dosing: 3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... Otherwise, it works ... #semaglutide #Diabetes ... #Pharmacology # ... Endocrinology
No results found for "Lellis pharmacology algorithm workup endocrinology diabetes dosing dm1 2018"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Lellis #pharmacology #algorithm #workup #endocrinology #diabetes #dosing #dm1 #2018